HK1043056B - 產生至少一個定時脈衝的控釋藥物劑型 - Google Patents

產生至少一個定時脈衝的控釋藥物劑型

Info

Publication number
HK1043056B
HK1043056B HK02104683.2A HK02104683A HK1043056B HK 1043056 B HK1043056 B HK 1043056B HK 02104683 A HK02104683 A HK 02104683A HK 1043056 B HK1043056 B HK 1043056B
Authority
HK
Hong Kong
Prior art keywords
dosage forms
controlled release
pharmaceutical dosage
timed pulse
release producing
Prior art date
Application number
HK02104683.2A
Other languages
English (en)
Other versions
HK1043056A1 (en
Inventor
Andre Frederic
Lewis Gareth
Mignonneau Jerome
Ribardiere Agnes
Original Assignee
聖諾菲-合成實驗室公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 聖諾菲-合成實驗室公司 filed Critical 聖諾菲-合成實驗室公司
Publication of HK1043056A1 publication Critical patent/HK1043056A1/xx
Publication of HK1043056B publication Critical patent/HK1043056B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
HK02104683.2A 1999-06-28 2002-06-24 產生至少一個定時脈衝的控釋藥物劑型 HK1043056B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99401606A EP1064938A1 (en) 1999-06-28 1999-06-28 Pharmaceutical dosage forms for controlled release producing at least a timed pulse
PCT/EP2000/006795 WO2001000182A1 (en) 1999-06-28 2000-06-27 Pharmaceutical dosage forms for controlled release producing at least a timed pulse

Publications (2)

Publication Number Publication Date
HK1043056A1 HK1043056A1 (en) 2002-09-06
HK1043056B true HK1043056B (zh) 2005-04-29

Family

ID=8242029

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02104683.2A HK1043056B (zh) 1999-06-28 2002-06-24 產生至少一個定時脈衝的控釋藥物劑型

Country Status (29)

Country Link
US (1) US20080175910A1 (zh)
EP (2) EP1064938A1 (zh)
JP (1) JP2003503341A (zh)
KR (1) KR100794402B1 (zh)
CN (2) CN1358088A (zh)
AR (1) AR024492A1 (zh)
AT (1) ATE274902T1 (zh)
AU (1) AU780769B2 (zh)
BR (1) BR0011999A (zh)
CA (1) CA2370067C (zh)
CO (1) CO5190681A1 (zh)
CZ (1) CZ296067B6 (zh)
DE (1) DE60013445T2 (zh)
DK (1) DK1194131T3 (zh)
ES (1) ES2225183T3 (zh)
HK (1) HK1043056B (zh)
HU (1) HU229312B1 (zh)
IL (2) IL146768A0 (zh)
MX (1) MXPA01013408A (zh)
NO (1) NO332952B1 (zh)
NZ (1) NZ515826A (zh)
PL (1) PL200816B1 (zh)
PT (1) PT1194131E (zh)
SI (1) SI1194131T1 (zh)
SK (1) SK285359B6 (zh)
TR (1) TR200103604T2 (zh)
TW (1) TWI242451B (zh)
WO (1) WO2001000182A1 (zh)
ZA (1) ZA200109849B (zh)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002252364B2 (en) 2001-03-13 2005-08-25 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
DE10149674A1 (de) 2001-10-09 2003-04-24 Apogepha Arzneimittel Gmbh Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
ZA200403281B (en) * 2001-11-07 2005-12-13 Synthon Bv Tamsulosin tablets.
CN1864663A (zh) * 2001-11-30 2006-11-22 辉瑞产品公司 5,7,14－三氮杂四环[10.3.1.0(2,11).0(4,9)]－十六碳－2(11)3,5,7,9－五烯的药物组合物
AU2002354497A1 (en) * 2001-12-19 2003-06-30 Sanwa Kagaku Kenkyusho Co., Ltd Release control type formed product
CA2491355A1 (en) * 2002-07-05 2004-01-15 Temrel Limited Controlled release compositions comprising coated pellets having non-uniform coating thicknesses
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
AU2003278407A1 (en) * 2002-10-22 2004-05-13 Ranbaxy Laboratories Limited Sustained release compositions containing alfuzosin
US7018658B2 (en) * 2002-11-14 2006-03-28 Synthon Bv Pharmaceutical pellets comprising tamsulosin
KR100592512B1 (ko) * 2002-11-22 2006-07-03 서울약품공업(주) 탐술로신 또는 약제학적으로 허용되는 이의 염을활성성분으로 하는 서방성 배뇨장애 치료제
IN192381B (zh) * 2002-12-20 2004-04-10 Ranbaxy Lab
EA200600598A1 (ru) * 2003-09-19 2006-08-25 Пенвест Фармасьютикалз Ко. Лекарственные формы замедленного высвобождения
AU2004273958A1 (en) * 2003-09-19 2005-03-31 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
GB2407498B (en) * 2003-10-30 2008-06-11 Cipla Ltd Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
KR100436701B1 (ko) * 2003-11-07 2004-06-22 주식회사 씨티씨바이오 염산 탐스로신 함유 방출 조절형 제제 및 그의 제조방법
US8292729B2 (en) 2003-12-02 2012-10-23 United Tote Company Methods and systems for presenting pari-mutuel betting options and constructing wagers
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
AR051654A1 (es) * 2004-11-04 2007-01-31 Astrazeneca Ab Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones
AR052225A1 (es) * 2004-11-04 2007-03-07 Astrazeneca Ab Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones
WO2006055659A2 (en) * 2004-11-15 2006-05-26 Smithkline Beecham Corporation Fixed dose combination op dutasteride and tamsulosin
EP1833467B1 (en) 2004-12-20 2016-08-03 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
EP1846382A2 (en) * 2005-01-26 2007-10-24 Elan Pharma International Limited Controlled release compositions comprising an antipsychotic agent
CA2601339A1 (en) * 2005-03-29 2006-10-05 Roehm Gmbh Multiparticulate pharmaceutical form comprising pellets with a matrix which influences the delivery of a modulatory substance
WO2007080509A2 (en) * 2006-01-12 2007-07-19 Wockhardt Ltd Sustained release compositions of alfuzosin
US20070292505A1 (en) * 2006-06-15 2007-12-20 Abrika Pharmaceuticals, Inc. Controlled release alfuzosin hydrochloride formulation
US20080095844A1 (en) * 2006-10-23 2008-04-24 Rajhans Sujay Kamalakar Sustained release pharmaceutical compositions of alfuzosin and process for preparation thereof
CN101269056B (zh) * 2007-03-19 2010-05-19 天津药物研究院 一种美托洛尔盐类口服脉冲微丸制剂
US8178483B2 (en) * 2007-03-30 2012-05-15 Colgate-Palmolive Company Polymeric encapsulates having a quaternary ammonium salt and methods for producing the same
JP5228359B2 (ja) * 2007-04-12 2013-07-03 ニプロ株式会社 主薬粒子及びその製造方法ならびに口腔内崩壊錠
FR2928929B1 (fr) * 2008-03-19 2012-01-13 Saint Gobain Composition serigraphiable sur polyvinylbutyral
WO2011049309A2 (ko) * 2009-10-09 2011-04-28 영진약품공업 주식회사 속효성과 지속성을 동시에 갖는 약제학적 조성물
CN102106841B (zh) * 2009-12-24 2013-01-09 杭州康恩贝制药有限公司 一种盐酸坦洛新制剂及其制备方法
CN102834091B (zh) 2010-03-29 2015-04-22 辉凌公司 一种快速溶解药物组合物
JO3112B1 (ar) 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
KR101686033B1 (ko) * 2010-04-12 2016-12-13 주식회사 대웅제약 탐술로신 또는 이의 약제학적 허용 가능한 염을 유효성분으로 함유하는 장용성 서방형 펠렛부와 속방부로 이루어진 의약 조성물
WO2011144994A1 (en) * 2010-05-21 2011-11-24 Lupin Limited Pharmaceutical compositions of nsaid and acid inhibitor
US8623409B1 (en) 2010-10-20 2014-01-07 Tris Pharma Inc. Clonidine formulation
TW201422254A (zh) * 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物
CN108347916B (zh) 2015-10-14 2022-02-08 先时迈纳米生物科技股份有限公司 一种减少冰晶形成的组合物及其方法
CN105362233A (zh) * 2015-12-07 2016-03-02 黑龙江省智诚医药科技有限公司 一种卡托普利缓释微丸及其制备方法
US10849856B2 (en) 2016-10-31 2020-12-01 Neurim Pharmaceuticals Ltd. Melatonin mini-tablets and method of manufacturing the same
MX2019004736A (es) * 2016-10-31 2019-06-17 Neurim Pharma 1991 Mini-tabletas de melatonina y metodos de fabricacion de las mismas.
US10278930B2 (en) 2017-03-16 2019-05-07 The Procter & Gamble Company Method for relieving sinus congestion
CN107233328A (zh) * 2017-06-13 2017-10-10 江苏黄河药业股份有限公司 卡托普利缓释片剂及其制备方法
CN107362161B (zh) * 2017-08-14 2020-05-29 黄河科技学院 一种复方卡托普利硝苯地平脉冲缓释制剂及其制备方法
TR201721036A2 (tr) * 2017-12-21 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Flurbi̇profeni̇n modi̇fi̇ye salimli formülasyonlari
JP7162330B2 (ja) * 2018-07-11 2022-10-28 株式会社アタゴ 粘度計
CN110075090A (zh) * 2019-05-17 2019-08-02 南京望知星医药科技有限公司 一种用于治疗呼吸疾病的沙丁胺醇胶囊及其制备方法
CN110037994B (zh) * 2019-05-24 2022-04-12 中国药科大学 一种布洛芬速释缓释双层片及其制备方法
US11918689B1 (en) 2020-07-28 2024-03-05 Tris Pharma Inc Liquid clonidine extended release composition

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA822995B (en) * 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
US4677099A (en) * 1981-09-04 1987-06-30 Yeda Research And Development Co., Ltd. Medical processes employing a novel lipid fraction
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
JPS58116414A (ja) * 1981-12-23 1983-07-11 Yamanouchi Pharmaceut Co Ltd ニカルジピン持続性製剤用球形顆粒およびその製造法
US4614796A (en) * 1983-03-25 1986-09-30 Nippon Shinyaku Co., Ltd. Liposome and method of manufacture therefor
DE3678643D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Partikel mit konstanter wirkstofffreisetzung.
US4986987A (en) * 1986-05-09 1991-01-22 Alza Corporation Pulsed drug delivery
US4994273A (en) * 1987-11-02 1991-02-19 Merck & Co., Inc. Solubility modulated drug delivery device
EP0386967B1 (en) * 1989-03-10 1995-07-12 Yamanouchi Pharmaceutical Co. Ltd. A drug-release controlling coating material for long acting formulations
US5176901A (en) * 1991-04-10 1993-01-05 Smithkline Beecham Corporation Dental composition
DE69222006T2 (de) * 1991-10-30 1998-01-22 Glaxo Group Ltd Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten
WO1993009785A1 (en) * 1991-11-22 1993-05-27 Procter & Gamble Pharmaceuticals, Inc. Risedronate delayed-release compositions
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
AU5681294A (en) * 1992-11-30 1994-06-22 Kv Pharmaceutical Company Tastemasked pharmaceutical materials
CA2161538A1 (en) * 1993-07-22 1995-02-02 S. Shirley Yang Controlled release tacrine drug delivery systems and methods for preparing same
FR2717388B1 (fr) * 1994-03-21 1996-11-22 Synthelabo Formes galéniques à libération prolongée du chlorhydrate d'alfuzosine.
US5834024A (en) * 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
IL139728A (en) * 1995-01-09 2003-06-24 Penwest Pharmaceuticals Compan Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
US6020375A (en) * 1997-06-13 2000-02-01 Senju Pharmaceutical Co., Ltd. Bactericidal composition
BR9802915A (pt) * 1997-09-12 2000-01-11 Oscar Gold Procedimento para formar composições farmaceuticas em pilulas ou granulos substancialmente esfericos, de ação controlada e continuada, contendo como agente ativo o (7-bromo-1,3-diidro-5-(2-piridninilo)-2h-1,4-benzodiazep ina-2(1h)-um)
US5922341A (en) * 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation
DK173431B1 (da) * 1998-03-20 2000-10-23 Gea Farmaceutisk Fabrik As Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs
US6124362A (en) * 1998-07-17 2000-09-26 The Procter & Gamble Company Method for regulating hair growth
US6270805B1 (en) * 1998-11-06 2001-08-07 Andrx Pharmaceuticals, Inc. Two pellet controlled release formulation for water soluble drugs which contains an alkaline metal stearate
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6495498B2 (en) * 1999-05-27 2002-12-17 Johnson & Johnson Consumer Companies, Inc. Detergent compositions with enhanced depositing, conditioning and softness capabilities

Also Published As

Publication number Publication date
AU6274700A (en) 2001-01-31
NO332952B1 (no) 2013-02-11
PT1194131E (pt) 2005-01-31
PL200816B1 (pl) 2009-02-27
DE60013445T2 (de) 2005-09-01
US20080175910A1 (en) 2008-07-24
CZ296067B6 (cs) 2006-01-11
NZ515826A (en) 2004-04-30
CZ20014639A3 (cs) 2002-04-17
TR200103604T2 (tr) 2002-04-22
IL146768A (en) 2010-05-17
IL146768A0 (en) 2002-07-25
CA2370067C (en) 2009-07-28
NO20016282L (no) 2002-02-27
SK285359B6 (sk) 2006-11-03
CN101669914A (zh) 2010-03-17
SK19102001A3 (sk) 2002-05-09
DE60013445D1 (de) 2004-10-07
CO5190681A1 (es) 2002-08-29
JP2003503341A (ja) 2003-01-28
PL354399A1 (en) 2004-01-12
ATE274902T1 (de) 2004-09-15
SI1194131T1 (en) 2005-04-30
WO2001000182A1 (en) 2001-01-04
AU780769B2 (en) 2005-04-14
CN1358088A (zh) 2002-07-10
TWI242451B (en) 2005-11-01
EP1064938A1 (en) 2001-01-03
HK1043056A1 (en) 2002-09-06
HU229312B1 (hu) 2013-10-28
MXPA01013408A (es) 2002-07-30
BR0011999A (pt) 2002-03-05
DK1194131T3 (da) 2005-01-17
HUP0202259A2 (hu) 2002-12-28
EP1194131B1 (en) 2004-09-01
NO20016282D0 (no) 2001-12-20
EP1194131A1 (en) 2002-04-10
CA2370067A1 (en) 2001-01-04
ES2225183T3 (es) 2005-03-16
ZA200109849B (en) 2003-02-26
AR024492A1 (es) 2002-10-02
KR100794402B1 (ko) 2008-01-16
KR20020015065A (ko) 2002-02-27
HUP0202259A3 (en) 2004-05-28

Similar Documents

Publication Publication Date Title
HUP0202259A3 (en) Pharmaceutical dosage forms for controlled release producing at least a timed pulse
HUP0301242A3 (en) Controlled release drug dosage form
IL153282A0 (en) Method for preparing a pharmaceutical composition
IL148407A0 (en) Oral pharmaceutical forms of administration with a delayed action
EG24851A (en) Crystalline anticholinergic process for the preparation thereof for preparing a medicament
EG24142A (en) Crystalline monohydrate, process for the preparation thereof and the use thereof for preparing a pharmaceutical composition
HUP0101437A3 (en) Oral pharmaceutical extended release dosage form
HK1041816A1 (zh) 藥片
HUP0200669A3 (en) Process for producing pharmaceutical preparation for oral administration containing tolperison
EP1207852A4 (en) ORAL PHARMACEUTICALS WITH TAXED RELEASE FOR ORAL ADMINISTRATION
HK1072194A1 (en) Oral dosage form for controlled drug release
AU145547S (en) A tablet for example a pharmaceutical tablet
AU1694501A (en) Method for producing a medicament
EP1114642A4 (en) MEDICAMENTS FOR THE TREATMENT OF PERIODONTAL DISEASES
AU145546S (en) A tablet for example a pharmaceutical tablet
IL144767A0 (en) Method for producing film-type dosage forms
IL151551A0 (en) Crystalline pharmaceutical
AU2001282071A1 (en) Multiparticulate pharmaceutical dosage form and a method for producing the same
AU3547001A (en) Method for producing pharmaceutical dosage forms
GB0001481D0 (en) System for delivering a medicament
PL354872A1 (en) Oral dosage form comprising a salt of morphine or a morphine derivative
HK1035237A1 (en) A method for auto-recovering a clock pulse setting
IL128582A0 (en) Pharmaceutical dosage form
GB9925620D0 (en) A method of forming a drug capsule for a needlefree injector
IL149853A0 (en) Gastroretentive controlled release pharmaceutical dosage forms

Legal Events

Date Code Title Description
CHPA Change of a particular in the register (except of change of ownership)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150627